HomeThe Insider’s ViewBusiness ProfilesFewer generics rush... Fewer generics rush to enter market after linagliptin's patent expiry Written by Karl Jörg October 19, 2023 Estimated reading time: Less than 1 minutes FacebookInstagramLinkedinTwitterYoutube Share FacebookPinterestWhatsAppLinkedinTelegramTwitterCopy URL 👁️ Post Views: 132,471 [ad_1] When Sitagliptin went off patent, nearly 200 brands were vying for a share of the market [ad_2] Source link Explore tags ⟶brand valuationLinagliptinPharmaceuticals firms Share FacebookPinterestWhatsAppLinkedinTelegramTwitterCopy URL Karl Jörghttps://modernbusinessworld.comGlobal Editor press release 10th All in Print China 2026 Brings Next-Generation Printing Technologies to Shanghai Karl Jörg - Automotive Megawatt charging impresses at Iaa Transpotation Full Charging of Trucks During the Rest Break Is Now Possible Karl Jörg - A Greener Choice: Constantia Flexibles and NÖM Unveil Paper-Based... Ajit Bhagwat - November 14, 2026 Sports IPL brand value soars 80% to $3.2 billion: Report Karl Jörg - Continue reading Pratush Bhaskar - November 14, 2026 press releaseMEDICA and COMPAMED 2026: Shaping the Future of Medical TechnologyMEDICA and COMPAMED 2026: Shaping the Future of Medical Technology Federal Health Minister Linnemann to attend the opening of the trade fair –... Ajit Bhagwat - November 13, 2026 press releasePRINT DIGITAL CONVENTION 2027 Sets the Stage for Smart Solutions and...PRINT DIGITAL CONVENTION 2027 Sets the Stage for Smart Solutions and New Opportunities Following its most successful edition to date in terms of... admin2 - November 10, 2026 publicSekrety, które zdradzają pracownicy kasyn co musisz wiedziećSekrety, które zdradzają pracownicy kasyn co musisz wiedzieć Zrozumienie psychologii gier Wielu pracowników kasyn podkreśla, że kluczowym elementem ich pracy jest zrozumienie psychologii graczy....